Home Cart Sign in  
Chemical Structure| 35212-22-7 Chemical Structure| 35212-22-7

Structure of Ipriflavone
CAS No.: 35212-22-7

Chemical Structure| 35212-22-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Ipriflavone is a synthetic isoflavone derivative used to prevent and treat osteoporosis.

Synonyms: 7-Isopropoxyisoflavone; Osteofix; TC 80

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Ipriflavone

CAS No. :35212-22-7
Formula : C18H16O3
M.W : 280.32
SMILES Code : O=C1C(C2=CC=CC=C2)=COC3=CC(OC(C)C)=CC=C13
Synonyms :
7-Isopropoxyisoflavone; Osteofix; TC 80
MDL No. :MFCD00221719
InChI Key :SFBODOKJTYAUCM-UHFFFAOYSA-N
Pubchem ID :3747

Safety of Ipriflavone

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Bovine chondrocytes 10 μM 3, 6, 9 days To investigate the effects of ipriflavone on GAG loss and HA molecular weight in bovine cartilage explants under IL-1β stimulation. Results showed that ipriflavone reduced GAG losses and increased the molecular weight of HA. Int J Mol Sci. 2023 Aug 4;24(15):12422
Fibroblast-like synoviocytes (FLS) 2 μM, 10 μM 24 hours Ipriflavone increased HA accumulation and suppressed MMP1 and MMP3 expression in TNF-α-stimulated FLS. Int J Mol Sci. 2022 Apr 7;23(8):4089
Rat chondrosarcoma (RCS) cells 1 μM, 5 μM, 10 μM, 20 μM 24 hours Ipriflavone significantly restored the Alcian blue staining of RCS-KIAA cells, dose-dependently increased extracellular matrix formation, and reduced HA leakage into the culture medium. Int J Mol Sci. 2022 Apr 7;23(8):4089
Primary tubular epithelial cells (PTCs) 200 nM Upregulated DHHC9 expression, downregulated β-catenin levels, and inhibited TGF-β1-induced fibronectin (FN) production Arthritis Res Ther. 2019 May 2;21(1):109
Primary neurons 5–20 μM IP suppressed tau hyperphosphorylation via GR/PI3K/AKT/GSK3β pathway Aging Cell. 2022 Mar;21(3):e13572
Human periodontal ligament cells (hPDLCs) 10^-7 M 24, 48, 72 hours Promote proliferation and osteogenic differentiation of hPDLCs Drug Des Devel Ther. 2018 Jan 11;12:137-148

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Male Sprague Dawley rats Dexamethasone-induced osteoporotic animal model Oral gavage 50 mg/kg Daily administration for 8 weeks To evaluate the therapeutic effect of Ipriflavone on dexamethasone-induced osteoporosis. Results showed that Ipriflavone significantly increased bone mineral density and bone mineral content, reduced bone resorption markers (such as TRAP and ACP), and improved bone histomorphology. Antioxidants (Basel). 2022 Mar 6;11(3):508
C57BL/6J mice Destabilization of the medial meniscus (DMM)-induced osteoarthritis model Oral 200 mg/kg/day Daily administration for 4, 6, 8, 10 weeks To evaluate the effects of ipriflavone on DMM-induced osteoarthritis in mice. Results showed that ipriflavone significantly reduced the Mankin score, decreased KIAA1199 expression, and preserved HA stainability. Int J Mol Sci. 2023 Aug 4;24(15):12422
DBA/1 J mice Collagen-induced arthritis (CIA) mouse model Oral 100 mg/kg, 200 mg/kg Once daily for 3 weeks Ipriflavone significantly improved the symptoms and reduced the serum concentrations of HA in CIA mice. Int J Mol Sci. 2022 Apr 7;23(8):4089
Mice STZ-induced diabetic mice and HFD/STZ-induced diabetic mice 20 and 40 mg/kg IP ameliorated diabetic cognitive impairment by antagonizing GR, including tau hyperphosphorylation, synaptic impairment, and neuroinflammation Aging Cell. 2022 Mar;21(3):e13572
Wistar rats Orthodontic tooth movement (OTM) model Intragastric administration 10 mg/kg/day Once daily for 10 days Promote periodontal tissue remodeling and bone formation Drug Des Devel Ther. 2018 Jan 11;12:137-148
Male mice Unilateral ureter obstruction (UUO) or ischemia/reperfusion injury (IRI)-induced kidney fibrosis models 0.3 mg/kg body weight/day Continued until the experimental endpoint Upregulated renal DHHC9 expression and alleviated UUO- or IRI-induced kidney fibrosis Arthritis Res Ther. 2019 May 2;21(1):109

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.57mL

0.71mL

0.36mL

17.84mL

3.57mL

1.78mL

35.67mL

7.13mL

3.57mL

References

 

Historical Records

Categories